Adaptimmune Therapeutics PLC·4

Jul 1, 5:02 PM ET

Hegde Priti 4

4 · Adaptimmune Therapeutics PLC · Filed Jul 1, 2024

Insider Transaction Report

Form 4
Period: 2024-07-01
Hegde Priti
Director
Transactions
  • Award

    Option to purchase Ordinary Shares

    2024-07-01+1,144,6861,144,686 total
    Exercise: $0.16From: 2025-07-01Exp: 2034-07-01Ordinary Shares (1,144,686 underlying)
Footnotes (1)
  • [F1]The exercise price was converted from GBP0.13 based on an exchange rate of $U.S. 1.263714 to GBP1.00. The actual exercise price will be the pounds sterling amount.

Documents

1 file
  • 4
    tm2418639-4_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT